Yan Gong

Yan Gong, Ph.D.

Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6297
Business Email: gong@cop.ufl.edu

About Yan Gong

Yan Gong, Ph.D., is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and the UF Center for Pharmacogenomics and Precision Medicine. Dr. Gong received a Ph.D. in Pharmaceutics in 2004 from Department of Pharmaceutics, College of Pharmacy at UF. She also obtained a Master’s Degree in Statistics in 2003 from UF Department of Statistics. Before joining the UF faculty in 2005, she completed one year of post-doctoral fellowship in Cardiovascular Pharmacogenomics at the UF Center for Pharmacogenomics.

Dr. Gong’s research focuses on pharmacogenomics of efficacy and adverse response of antihypertensives medications, and serious adverse drug events such as medication-related osteonecrosis of the jaw (ONJ) and cardiotoxicities related to cancer therapies (Cardio-Oncology). Dr. Gong is a NIH-funded investigator for multiple R01s and U01s. Dr. Gong was also funded by the Clinical and Translational Science Institute (CTSI) to 1). develop a computable phenotype for cancer drug induced cardiotoxicity in the Electronic Health Records in order to evaluate this clinically significant adverse event in the real-world settings of OneFlorida Clinical Research Consortium; 2). To identify pharmacogenomic, medical imaging biomarkers and clinical factors associated with cardiotoxicity related to cancer therapies through a multimodal approach using existing data from the UK Biobank. Dr. Gong is also leading the newly established Cardio-Oncology Research Interest Group in the Cardiovascular Collaborative Research Group of the National Patient-centered Clinical Research Network (PCORnet). Dr. Gong has authored over 140 peer-reviewed publications.

https://www.ncbi.nlm.nih.gov/myncbi/yan.gong.1/bibliography/public/

In addition to research, Dr. Gong has been involved in teaching multiple graduate level and professional level courses at the UF College of Pharmacy and College of Medicine. She is currently the course coordinator for Pharmacogenomics (PHA6449), a required graduate level course for the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy.

Publications

2015 Cancer Treatment Reviews
2014 Journal of the American Society of Hypertension

Grants

Sep 2018 ACTIVE
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD · Project Manager
Aug 2018 ACTIVE
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
NATL INST OF HLTH NICHD ·
Apr 2017 ACTIVE
HSC COM Matching Commitment
UNIV OF FLORIDA · Project Manager
Apr 2017 ACTIVE
OoR CTSI Institutional Matching Support
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
Jul 2016 ACTIVE
A stem cell tactic to promote personalized medicine
NATL INST OF HLTH NIGMS · Project Manager
Jun 2016 – Aug 2018
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD ·
Oct 2015 – Mar 2019
OneFlorida Clinical Research Consortium Phase II
PATIENT-CENTERED OUTCOMES RES INST ·
Apr 2015 ACTIVE
Clinical and Translational Science Institute (CTSI)
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
Jun 2014 ACTIVE
Mechanisms and Treatment Response of Aggressive Periodontitis in Children
NATL INST OF HLTH NIDCR · Project Manager

Education

Ph.D.
2004 · University of Florida
M.S.
2003 · University of Florida
M.S.
1999 · West China University of Medical Sciences

Contact Details

Phones:
Business:
(352) 273-6297
Emails:
Business:
gong@cop.ufl.edu